# Bristol-Myers Squibb Company (BMY) — Q3-2023 Earnings Results

**Report date:** 2023-10-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2023

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 6.43%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.00 | N/A | +13.64% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth despite current market pressures. They emphasized their commitment to innovation and addressing challenges head-on.

**Key quotes:**

> Management highlighted the continued strength of their pipeline.

> They acknowledged challenges in the market but remain focused on long-term goals.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise on EPS, indicating stronger-than-expected profitability. However, the stock fell by 6.43%, likely due to a lack of revenue details and no guidance for the future. Investors may be concerned about market conditions and the company's ability to navigate them.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2023_